Effects of Light vs. Heavy Paraffin Oil on Embryo Culture in IVF: A Prospective Study on Development and Pregnancy Rate
1 other identifier
interventional
818
1 country
1
Brief Summary
This prospective study aims to compare the effects of light and heavy paraffin oil in embryo culture during in vitro fertilization (IVF). Paraffin oil is commonly used in IVF laboratories to protect embryo culture media from evaporation and temperature fluctuations. However, the impact of different oil viscosities on embryo development and pregnancy outcomes remains unclear. Participants undergoing IVF treatment will have their embryos cultured under either light or heavy paraffin oil conditions. The study will evaluate key outcomes, including embryo development, blastocyst formation rates, and pregnancy rates. Findings from this research may help optimize embryo culture conditions, potentially improving IVF success rates and guiding best laboratory practices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedFirst Submitted
Initial submission to the registry
February 16, 2025
CompletedFirst Posted
Study publicly available on registry
February 21, 2025
CompletedFebruary 21, 2025
February 1, 2025
7 months
February 16, 2025
February 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Fertilization Rate
The proportion of oocytes that successfully undergo fertilization after insemination, as determined by the presence of two pronuclei (2PN) at the appropriate time post-fertilization.
16-20 hours post-insemination
Cleavage Rate
The proportion of fertilized oocytes that progress to cleavage-stage embryos, assessed by the number of embryos that reach at least the two-cell stage within 48 hours after fertilization.
48 hours post-fertilization
Blastocyst Formation Rate
The proportion of embryos that successfully develop into blastocysts by Day 5 or Day 6 of culture, assessed based on morphological grading criteria.
5-6 days post-fertilization
Secondary Outcomes (6)
Positive Beta-hCG
14 days post-embryo transfer
Implantation Rate
4-5 weeks post-embryo transfer
Clinical Pregnancy Rate
6-7 weeks post-embryo transfer
Ongoing Pregnancy Rate
12 weeks post-embryo transfer
Live Birth Rate
At delivery (up to ~40 weeks of gestation)
- +1 more secondary outcomes
Study Arms (2)
Light Paraffin Oil Group
EXPERIMENTALEmbryos are cultured under light paraffin oil conditions.
Heavy Paraffin Oil Group
EXPERIMENTALEmbryos are cultured under heavy paraffin oil conditions. Thus, the Number of Arms = 2.
Interventions
Embryos in this group will be cultured under conditions using light paraffin oil as an overlay in in vitro fertilization (IVF). The oil serves to protect the culture media from evaporation and temperature fluctuations. Key outcomes, including embryo development, blastocyst formation rate, and pregnancy rate, will be assessed.
Embryos in this group will be cultured under conditions using heavy paraffin oil as an overlay in in vitro fertilization (IVF). This study aims to compare the effects of heavy paraffin oil to light paraffin oil in embryo culture, assessing embryo development, blastocyst formation, and pregnancy rates.
Eligibility Criteria
You may qualify if:
- Women undergoing in vitro fertilization (IVF) treatment with planned embryo culture.
- Patients with normal ovarian function or undergoing ovarian stimulation for IVF.
- Willingness to participate and provide informed consent.
You may not qualify if:
- Presence of severe uterine abnormalities (e.g., congenital malformations, Asherman's syndrome).
- History of recurrent implantation failure (≥3 unsuccessful IVF attempts).
- Poor ovarian response (e.g., ≤3 oocytes retrieved in a previous IVF cycle).
- Presence of severe male factor infertility, requiring testicular sperm extraction (TESE) or micro-TESE.
- Use of pre-implantation genetic testing (PGT) for embryo selection.
- Known autoimmune disorders or uncontrolled chronic conditions (e.g., diabetes, thyroid disorders) that may affect pregnancy outcomes.
- Participation in another clinical trial that may interfere with study outcomes.
- Donor cycles or surrogacy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hung Vuong Hospital
Ho Chi Minh City, 700000, Vietnam
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 16, 2025
First Posted
February 21, 2025
Study Start
May 23, 2023
Primary Completion
December 31, 2023
Study Completion
January 15, 2025
Last Updated
February 21, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to concerns regarding patient confidentiality and privacy, in accordance with ethical guidelines and regulatory requirements for fertility treatment studies. Additionally, since this study involves sensitive reproductive health data, data sharing is restricted to aggregate-level results to protect participant anonymity. However, summary findings and statistical analyses will be made available through peer-reviewed publications and conference presentations to ensure transparency and contribution to scientific knowledge.